T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Completed · Phase 3

Conditions studied: HIV Infections

In brief

The purpose of this study is to compare the change in viral load (amount of HIV in the blood) of patients who receive T-20 with selected anti-HIV drugs to that of patients who receive only selected anti-HIV drugs.

Key facts

Study ID

NCT00008528

Run by

Hoffmann-La Roche

People needed

525

Last updated by the study team

2005-06-24

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are HIV-infected.
• Are at least 16 years old (have consent of parent or guardian if under 18).
• Have a viral load (level of HIV in the blood) of 5,000 copies/ml or more.
• Have received anti-HIV drugs for at least 6 months and/or have shown resistance to each of the 3 types of anti-HIV drugs as follows: nucleoside reverse transcriptase inhibitors (resistant to 1 or more); nonnucleoside reverse transcriptase inhibitors (resistant to 1 or more); and protease inhibitors (resistant to 2 or more, taken either together or 1 after the other for at least 6 months total).

Where it is running

• Univ of Alabama at Birmingham — Birmingham, Alabama, United States
• Phoenix Body Positive — Phoenix, Arizona, United States
• Pacific Oaks Med Group — Beverly Hills, California, United States
• AIDS Healthcare Foundation — Los Angeles, California, United States
• Univ of California, San Diego — San Diego, California, United States
• San Francisco Gen Hosp — San Francisco, California, United States
• San Francisco VA Med Ctr — San Francisco, California, United States
• Univ of Colorado Health Sciences Ctr — Denver, Colorado, United States
• Whitman Walker Clinic/Elizabeth Taylor Med Ctr — Washington D.C., District of Columbia, United States
• IDC Research Initiative — Altamonte Springs, Florida, United States
• Steinhart Medical Associates — Miami, Florida, United States
• AIDS Research Consortium of Atlanta — Atlanta, Georgia, United States
• Trevor Slom — Chicago, Illinois, United States
• Indiana Univ Hosp — Indianapolis, Indiana, United States
• New England Med Ctr — Boston, Massachusetts, United States
• Massachusetts Gen Hosp — Boston, Massachusetts, United States
• Community Research Initiative of New England — Brookline, Massachusetts, United States
• Regions Hosp — Saint Paul, Minnesota, United States
• Albany Med College — Albany, New York, United States
• Peter Tsang — New York, New York, United States
• Columbia Presbyterian Med Ctr — New York, New York, United States
• Univ of North Carolina / SOCA — Chapel Hill, North Carolina, United States
• Univ of Cincinnati — Cincinnati, Ohio, United States
• Case Western Reserve Univ / AIDS Clinical Trials Unit — Cleveland, Ohio, United States
• Oregon Health Sciences Univ — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.